Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
kidney disease
Pharma
Hansa eyes FDA filing after ph. 3 win for kidney transplant med
With a late-stage win in hand, Sweden’s Hansa Biopharma is one step closer to bringing its kidney transplant drug imlifidase to the U.S.
Fraiser Kansteiner
Sep 25, 2025 12:37pm
Apellis snatches broad kidney disease expansion for Empaveli
Jul 28, 2025 8:00pm
Sobi places $300M bet on Empaveli in partnership with Apellis
Jul 1, 2025 11:28am
Pfizer CEO, Otsuka, Novartis-MSN—Fierce Pharma Asia
Jun 13, 2025 9:18am
Travere taps Grammy-winning producer to create patient anthem
Jun 10, 2025 12:18pm
Second Novartis drug in IgAN troika crosses FDA finish line
Apr 3, 2025 10:56am
